Page last updated: 2024-10-25

clofibrate and Neoplasms

clofibrate has been researched along with Neoplasms in 26 studies

angiokapsul: contains clofibrate & insoitolnicotinate

Neoplasms: New abnormal growth of tissue. Malignant neoplasms show a greater degree of anaplasia and have the properties of invasion and metastasis, compared to benign neoplasms.

Research Excerpts

ExcerptRelevanceReference
" In addition, characterization of the UGT1A locus and genetic studies directed at understanding the role of bilirubin glucuronidation and the biochemical basis of the clinical symptoms found in unconjugated hyperbilirubinemia have uncovered the structural gene polymorphisms associated with Crigler-Najjar's and Gilbert's syndrome."4.80Human UDP-glucuronosyltransferases: metabolism, expression, and disease. ( Strassburg, CP; Tukey, RH, 2000)
"Sphingosine kinase (SphK) is an oncogenic lipid kinase that regulates the sphingolipid metabolic pathway that has been shown to play a role in numerous hyperproliferative/inflammatory diseases."2.50Importance of sphingosine kinase (SphK) as a target in developing cancer therapeutics and recent developments in the synthesis of novel SphK inhibitors. ( Amin, S; Plano, D; Sharma, AK, 2014)

Research

Studies (26)

TimeframeStudies, this research(%)All Research%
pre-199017 (65.38)18.7374
1990's2 (7.69)18.2507
2000's3 (11.54)29.6817
2010's4 (15.38)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Willson, TM1
Brown, PJ1
Sternbach, DD1
Henke, BR1
Tukey, RH1
Strassburg, CP1
Diamandis, P1
Wildenhain, J1
Clarke, ID1
Sacher, AG1
Graham, J1
Bellows, DS1
Ling, EK1
Ward, RJ1
Jamieson, LG1
Tyers, M1
Dirks, PB1
Lin, R1
Elf, S1
Shan, C1
Kang, HB1
Ji, Q1
Zhou, L1
Hitosugi, T1
Zhang, L1
Zhang, S1
Seo, JH1
Xie, J1
Tucker, M1
Gu, TL1
Sudderth, J1
Jiang, L1
Mitsche, M1
DeBerardinis, RJ1
Wu, S1
Li, Y1
Mao, H1
Chen, PR1
Wang, D1
Chen, GZ1
Hurwitz, SJ1
Lonial, S1
Arellano, ML1
Khoury, HJ1
Khuri, FR1
Lee, BH1
Lei, Q1
Brat, DJ1
Ye, K1
Boggon, TJ1
He, C1
Kang, S1
Fan, J1
Chen, J1
Plano, D1
Amin, S1
Sharma, AK1
Penna, F1
Bonelli, G1
Baccino, FM1
Costelli, P1
Oliver, MF2
Heller, RF1
Heller, F1
Pourbaix, S1
Epstein, LH1
Fabbrocini, V1
Boumendil, EF1
Balkau, B1
Charles, MA1
Eschwège, E1
Downie, CC1
Dilman, VM2
Gianoulakis, C1
Nestruck, AC1
Lis, M1
Davignon, J1
Chrétien, M1
Wedel, H1
Vedin, A1
Wilhelmsen, L1
de Gennes, JL1
Schiffman, FJ1
Fisher, JM1
Rabinovitz, M1
Dil'man, VM1
Bershteĭn, LM1
Tsyrlina, EV1
Bobrov, IuF1
Kovaleva, IG2
Revskoy, SY1
Poroshina, TE1
Berstein, LM1
Ostroumova, MN1
Fenwick, GR1
Hanley, AB1

Reviews

8 reviews available for clofibrate and Neoplasms

ArticleYear
The PPARs: from orphan receptors to drug discovery.
    Journal of medicinal chemistry, 2000, Feb-24, Volume: 43, Issue:4

    Topics: Animals; Diabetes Mellitus; Drug Design; Humans; Hyperlipidemias; Hypertension; Inflammation; Ligand

2000
Human UDP-glucuronosyltransferases: metabolism, expression, and disease.
    Annual review of pharmacology and toxicology, 2000, Volume: 40

    Topics: Autoimmunity; Chromosome Mapping; Glucuronides; Glucuronosyltransferase; Humans; Hyperbilirubinemia;

2000
6-Phosphogluconate dehydrogenase links oxidative PPP, lipogenesis and tumour growth by inhibiting LKB1-AMPK signalling.
    Nature cell biology, 2015, Volume: 17, Issue:11

    Topics: AMP-Activated Protein Kinase Kinases; AMP-Activated Protein Kinases; Humans; Lipogenesis; Neoplasms;

2015
Importance of sphingosine kinase (SphK) as a target in developing cancer therapeutics and recent developments in the synthesis of novel SphK inhibitors.
    Journal of medicinal chemistry, 2014, Jul-10, Volume: 57, Issue:13

    Topics: Clofibrate; Drug Combinations; Enzyme Inhibitors; Humans; Isoenzymes; Lysophospholipids; Neoplasms;

2014
Cytotoxic properties of clofibrate and other peroxisome proliferators: relevance to cancer progression.
    Current medicinal chemistry, 2010, Volume: 17, Issue:4

    Topics: Animals; Clofibrate; Cytotoxins; Disease Progression; Humans; Neoplasms; Peroxisome Proliferator-Act

2010
[Peroxisomes and hypolipidemic agents ].
    La semaine des hopitaux : organe fonde par l'Association d'enseignement medical des hopitaux de Paris, 1982, Jul-08, Volume: 58, Issue:28-29

    Topics: Animals; Clofibrate; Cricetinae; Energy Metabolism; Female; Humans; Hydrogen Peroxide; Hypolipidemic

1982
The direct effects of compliance on health outcome.
    Health psychology : official journal of the Division of Health Psychology, American Psychological Association, 1984, Volume: 3, Issue:4

    Topics: Alcoholism; Chlorpromazine; Chorionic Gonadotropin; Clofibrate; Coronary Disease; Disulfiram; Drug T

1984
The genus Allium--Part 3.
    Critical reviews in food science and nutrition, 1985, Volume: 23, Issue:1

    Topics: Allium; Animals; Arteriosclerosis; Asthma; Bacteria; Blood Glucose; Blood Protein Electrophoresis; C

1985

Trials

7 trials available for clofibrate and Neoplasms

ArticleYear
WHO cooperative trial on primary prevention of ischaemic heart disease with clofibrate to lower serum cholesterol: final mortality follow-up. Report of the Committee of Principal Investigators.
    Lancet (London, England), 1984, Sep-15, Volume: 2, Issue:8403

    Topics: Cholesterol; Clinical Trials as Topic; Clofibrate; Coronary Disease; Follow-Up Studies; Humans; Male

1984
The direct effects of compliance on health outcome.
    Health psychology : official journal of the Division of Health Psychology, American Psychological Association, 1984, Volume: 3, Issue:4

    Topics: Alcoholism; Chlorpromazine; Chorionic Gonadotropin; Clofibrate; Coronary Disease; Disulfiram; Drug T

1984
Clofibrate.
    Lancet (London, England), 1979, Feb-10, Volume: 1, Issue:8111

    Topics: Clinical Trials as Topic; Clofibrate; Coronary Disease; Drug Evaluation; Humans; Hyperlipidemias; Ne

1979
A co-operative trial in the primary prevention of ischaemic heart disease using clofibrate. Report from the Committee of Principal Investigators.
    British heart journal, 1978, Volume: 40, Issue:10

    Topics: Adult; Cardiovascular Diseases; Cholelithiasis; Cholesterol; Clinical Trials as Topic; Clofibrate; C

1978
Cholesterol, coronaries, clofibrate and death.
    The New England journal of medicine, 1978, Dec-14, Volume: 299, Issue:24

    Topics: Adult; Cholesterol; Clinical Trials as Topic; Clofibrate; Coronary Disease; Death, Sudden; Humans; H

1978
[Increased mortality with clofibrate].
    Lakartidningen, 1979, Jan-31, Volume: 76, Issue:5

    Topics: Adult; Cardiovascular Diseases; Clinical Trials as Topic; Clofibrate; Double-Blind Method; Humans; M

1979
[Real or alleged risks of clofibrate derivatives and certain risks of their prohibition].
    La Nouvelle presse medicale, 1979, Mar-31, Volume: 8, Issue:15

    Topics: Adult; Arteriosclerosis; Cholelithiasis; Clinical Trials as Topic; Clofibrate; Coronary Disease; Eur

1979

Other Studies

12 other studies available for clofibrate and Neoplasms

ArticleYear
Chemical genetics reveals a complex functional ground state of neural stem cells.
    Nature chemical biology, 2007, Volume: 3, Issue:5

    Topics: Animals; Cell Survival; Cells, Cultured; Mice; Molecular Structure; Neoplasms; Neurons; Pharmaceutic

2007
Cholesterol-lowering and cancer in the prevention of cardiovascular disease.
    QJM : monthly journal of the Association of Physicians, 2010, Volume: 103, Issue:3

    Topics: Cardiovascular Diseases; Clofibrate; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperch

2010
The clofibrate problem: a different viewpoint.
    Lancet (London, England), 1980, Nov-15, Volume: 2, Issue:8203

    Topics: Animals; Biotransformation; Clofibrate; Coronary Disease; Humans; Neoplasms; Phenoxyacetates; Rats

1980
Coronary heart disease, cancer, lipoproteins, and the effects of clofibrate: is enzyme induction a common link and are lipoproteins red herrings?
    Lancet (London, England), 1981, Dec-05, Volume: 2, Issue:8258

    Topics: Carcinogens; Cholesterol; Cholesterol, HDL; Clofibrate; Coronary Disease; Enzyme Induction; Humans;

1981
[Study of clofibrate. The opinion of Prof. D. Kritchevsky].
    Minerva cardioangiologica, 1980, Volume: 28, Issue:11

    Topics: Adult; Arteriosclerosis; Cholelithiasis; Clofibrate; Coronary Disease; Drug Evaluation; Humans; Hype

1980
Mortality from non-cardiovascular disease and diabetes mellitus.
    Lancet (London, England), 1998, Feb-21, Volume: 351, Issue:9102

    Topics: Anticholesteremic Agents; Cardiovascular Diseases; Cause of Death; Clofibrate; Diabetes Mellitus; Fr

1998
High death rate from neoplasms in French diabetic and non-diabetic men.
    Lancet (London, England), 1998, May-16, Volume: 351, Issue:9114

    Topics: Case-Control Studies; Clofibrate; Diabetes Mellitus; Humans; Hyperlipidemias; Hypolipidemic Agents;

1998
Ageing, metabolic immunodepression and carcinogenesis.
    Mechanisms of ageing and development, 1978, Volume: 8, Issue:3

    Topics: Adult; Aged; Aging; Cell Transformation, Neoplastic; Cholesterol; Clofibrate; Coronary Disease; Diab

1978
Experimental hyperlipidemia in rats.
    Annales de la nutrition et de l'alimentation, 1979, Volume: 33, Issue:1

    Topics: Adipose Tissue; Adrenocorticotropic Hormone; Animals; Blood Pressure; Cholesterol; Clofibrate; Cycli

1979
Serum displacing agents in cancer chemotherapy.
    Cancer treatment reports, 1977, Volume: 61, Issue:7

    Topics: Animals; Cattle; Cells, Cultured; Chemical Phenomena; Chemistry; Chlorambucil; Clofibrate; Culture M

1977
[Correction of endocrine-metabolic disorders in oncologic patients. The effect of biguanides (phenformin and adebita), miskleron and diphenin].
    Voprosy onkologii, 1975, Volume: 21, Issue:11

    Topics: Adrenal Cortex Hormones; Aged; Biguanides; Blood Glucose; Body Weight; Breast Neoplasms; Buformin; C

1975
Age-dependent metabolic immunodepression and cancer.
    IARC scientific publications, 1985, Issue:58

    Topics: Age Factors; Biguanides; Blood Viscosity; Breast Neoplasms; Cholesterol; Clofibrate; Female; Humans;

1985